Literature DB >> 22442819

Multiplex analysis of cytokines, chemokines, growth factors, MMP-9 and TIMP-1 produced by human bone marrow, adipose tissue, and placental mesenchymal stromal cells.

A A Ostanin1, Ya L Petrovskii, E Ya Shevela, E R Chernykh.   

Abstract

Comparative analysis of mesenchymal stromal cells isolated from human BM, adipose tissue, and placenta was carried out. The cells were compared by the levels of constitutive, spontaneous, and LPS-induced production of Th1/proinflammatory (IFN-γ, IL-2, IL-1β, TNF-α, IL-12, IL-17) and Th2/anti-inflammatory cytokines (IL-4, IL-5, IL-6, IL-10, IL-13), chemokines (IL-8, MCP-1, MIP-1β), growth factors (IL-7, granulocytic CSF, granulocytic macrophageal CSF, erythropoietin, VEGF, EGF, IGF-1, main FGF), matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1. Mesenchymal stromal cells originating from different tissues were characterized by functional potential for hemopoiesis support (through production of granulocytic CSF, granulocytic macrophage CSF, erythropoietin), immunomodulation (through production of IFN-γ, IL-2, IL-6, IL-1β, TNF-α and chemokines IL-8, MCP-1, MIP-1β), and stimulation of reparative processes (through production of VEGF, FGF, IGF-1, IL-6 tissue inhibitor of metalloproteinase-1, and matrix metalloproteinase-9). By the type and levels of spontaneous (basal) production of cytokines, the adipose tissue mesenchymal stromal cells more distinctly demonstrated the proinflammatory (IL-1β TNF-α), immunoregulatory (IFN-γ, IL-2, IL-4, IL-6, IL-8, MCP-1, MIP-1β), and hemopoiesis-stimulating (granulocytic CSF, granulocytic macrophage CSF) phenotype and at the same time were characterized by lower sensitivity to lipopolysaccharide stimulation than BM and placental mesenchymal cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22442819     DOI: 10.1007/s10517-011-1275-2

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  14 in total

1.  Unique serum immune phenotypes stratify Oklahoma Native American rheumatic disease patients.

Authors:  Samantha Slight-Webb; Carla J Guthridge; Joseph Kheir; Hua Chen; Ly Tran; Tim Gross; Virginia Roberts; Sohail Khan; Michael Peercy; Bobby Saunkeah; Joel M Guthridge; Judith A James
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-10-01       Impact factor: 4.794

2.  Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis.

Authors:  Luigino Calzetta; Marina Aiello; Annalisa Frizzelli; Francesca Camardelli; Mario Cazzola; Paola Rogliani; Alfredo Chetta
Journal:  Cells       Date:  2022-05-30       Impact factor: 7.666

3.  Concentrated Conditioned Media from Adipose Tissue Derived Mesenchymal Stem Cells Mitigates Visual Deficits and Retinal Inflammation Following Mild Traumatic Brain Injury.

Authors:  Kumar Abhiram Jha; Mickey Pentecost; Raji Lenin; Lada Klaic; Sally L Elshaer; Jordy Gentry; John M Russell; Alex Beland; Anton Reiner; Veronique Jotterand; Nicolas Sohl; Rajashekhar Gangaraju
Journal:  Int J Mol Sci       Date:  2018-07-11       Impact factor: 5.923

4.  Human Bone Marrow-Derived Mesenchymal Stromal Cells Differentially Inhibit Cytokine Production by Peripheral Blood Monocytes Subpopulations and Myeloid Dendritic Cells.

Authors:  Paula Laranjeira; Joana Gomes; Susana Pedreiro; Monia Pedrosa; Antonio Martinho; Brigida Antunes; Tania Ribeiro; Francisco Santos; Rosario Domingues; Manuel Abecasis; Helder Trindade; Artur Paiva
Journal:  Stem Cells Int       Date:  2015-04-28       Impact factor: 5.443

5.  Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.

Authors:  Andreia Ribeiro; Paula Laranjeira; Sandrine Mendes; Isabel Velada; Cristiana Leite; Pedro Andrade; Francisco Santos; Ana Henriques; Mário Grãos; Carla M P Cardoso; António Martinho; Mluísa Pais; Cláudia Lobato da Silva; Joaquim Cabral; Hélder Trindade; Artur Paiva
Journal:  Stem Cell Res Ther       Date:  2013-10-15       Impact factor: 6.832

6.  Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema.

Authors:  Mariana A Antunes; Soraia C Abreu; Fernanda F Cruz; Ana Clara Teixeira; Miquéias Lopes-Pacheco; Elga Bandeira; Priscilla C Olsen; Bruno L Diaz; Christina M Takyia; Isalira P R G Freitas; Nazareth N Rocha; Vera L Capelozzi; Débora G Xisto; Daniel J Weiss; Marcelo M Morales; Patricia R M Rocco
Journal:  Respir Res       Date:  2014-10-03

Review 7.  Mesenchymal stromal cell therapy in COPD: from bench to bedside.

Authors:  Mariana A Antunes; José Roberto Lapa E Silva; Patricia Rm Rocco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-16

8.  Bone Marrow, Adipose, and Lung Tissue-Derived Murine Mesenchymal Stromal Cells Release Different Mediators and Differentially Affect Airway and Lung Parenchyma in Experimental Asthma.

Authors:  Soraia C Abreu; Mariana A Antunes; Debora G Xisto; Fernanda F Cruz; Vivian C Branco; Elga Bandeira; Jamil Zola Kitoko; Almair F de Araújo; Ludmilla Dellatorre-Texeira; Priscilla C Olsen; Daniel J Weiss; Bruno L Diaz; Marcelo M Morales; Patricia R M Rocco
Journal:  Stem Cells Transl Med       Date:  2017-04-20       Impact factor: 6.940

9.  A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.

Authors:  Hussein Ghamlouch; Hakim Ouled-Haddou; Gandhi Damaj; Bruno Royer; Brigitte Gubler; Jean-Pierre Marolleau
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

Review 10.  Can Youthful Mesenchymal Stem Cells from Wharton's Jelly Bring a Breath of Fresh Air for COPD?

Authors:  Andrzej M Janczewski; Joanna Wojtkiewicz; Ewa Malinowska; Anna Doboszyńska
Journal:  Int J Mol Sci       Date:  2017-11-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.